You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 12, 2025

Drug Price Trends for POLY BACITRACIN OINTMENT


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for POLY BACITRACIN OINTMENT

Average Pharmacy Cost for POLY BACITRACIN OINTMENT

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug NameNDCPrice/Unit ($)UnitDate
POLY BACITRACIN OINTMENT 70000-0070-01 0.13893 GM 2025-03-19
POLY BACITRACIN OINTMENT 70000-0070-01 0.13836 GM 2025-02-19
POLY BACITRACIN OINTMENT 70000-0093-01 0.15857 GM 2025-02-19
POLY BACITRACIN OINTMENT 70000-0093-01 0.15696 GM 2025-01-22
POLY BACITRACIN OINTMENT 70000-0070-01 0.13779 GM 2025-01-22
POLY BACITRACIN OINTMENT 70000-0070-01 0.13722 GM 2024-12-18
>Drug Name>NDC>Price/Unit ($)>Unit>Date
Showing 1 to 6 of 6 entries

Market Analysis and Price Projections for Bacitracin/Polymyxin B Ointment

Introduction

Bacitracin/Polymyxin B ointment is a widely used antimicrobial agent, particularly for treating superficial ocular and skin infections. This article delves into the market analysis, price projections, and other relevant factors influencing the demand and supply of this medication.

Market Overview

The global market for peptide antibiotics, which includes Bacitracin and Polymyxin B, is experiencing significant growth. As of 2021, the global peptide antibiotics market was valued at USD 4.37 billion and is expected to expand at a compound annual growth rate (CAGR) of 4.6% from 2022 to 2030, reaching USD 6.6 billion by 2030[4].

Segment Analysis

  • Product Type: The non-ribosomal synthesized peptide antibiotics segment, which includes Bacitracin and Polymyxin B, held the largest revenue share of 72.2% in 2021 and is likely to maintain its dominance over the forecast period[4].
  • Disease Outlook: The segment for skin infections and ophthalmic infections, where Bacitracin/Polymyxin B ointment is commonly used, is a significant driver of market growth. The rising incidence of bacterial skin and ophthalmic infections is expected to drive demand for this medication[4].
  • Route of Administration: The topical route of administration, which includes ointments like Bacitracin/Polymyxin B, is growing due to the increasing prescriptions for bacterial skin and ophthalmic infections[4].

Price Projections

Current Pricing

The cost for Bacitracin/Polymyxin B topical ointment can vary depending on the quantity and pharmacy. For a supply of 28.4 grams, the price is around $12.33, with prices ranging from $0.43 to $0.93 per unit depending on the quantity purchased[2].

Future Pricing Trends

Given the overall growth in the peptide antibiotics market, it is likely that the prices of Bacitracin/Polymyxin B ointment will remain stable or see a slight increase. However, factors such as competition, manufacturing costs, and regulatory changes can influence pricing.

Discounts and Assistance Programs

Patients can benefit from discount cards and copay programs, which can reduce the cost of the medication. For example, the Drugs.com Discount Card can save up to 80% or more off the cost of prescription medicines and over-the-counter drugs[2][5].

Supply and Demand

Global Supply

The global supply of Bacitracin Zinc Ointment is expected to grow, driven by increasing demand for antimicrobial agents. The market size for Bacitracin Zinc Ointment is projected to rise, although specific figures for the ointment formulation are not detailed in available reports[3].

Demand Drivers

  • Increasing Infections: The rising incidence of bacterial infections, particularly skin and ophthalmic infections, is a major driver of demand for Bacitracin/Polymyxin B ointment.
  • Antimicrobial Resistance: The growing concern over antimicrobial resistance has led to increased research and development in peptide antibiotics, further driving demand[4].

Distribution Channels

Retail Pharmacies

Retail pharmacies hold a significant share of the distribution channel for Bacitracin/Polymyxin B ointment. This segment is expected to register the fastest growth rate during the forecast period due to rising prescriptions for bacterial infections[4].

Hospital Pharmacies

Hospital pharmacies also play a crucial role, especially for more severe infections requiring hospital care. This segment held the highest revenue share in 2021 but is expected to grow at a slower rate compared to retail pharmacies[4].

Key Producers and Market Competition

The market for Bacitracin/Polymyxin B ointment is competitive, with several key producers. Companies like Xellia Pharmaceuticals are notable for their robust product portfolios in peptide antibiotics, including Bacitracin and Polymyxin B[4].

Regulatory Environment

Regulatory changes and compliance requirements can impact the production and pricing of Bacitracin/Polymyxin B ointment. Manufacturers must adhere to strict guidelines to ensure the quality and safety of the product.

Consumer Perspective

Patient Resources

Patients can access various resources, including discount cards, copay programs, and patient assistance programs, although specific programs for Bacitracin/Polymyxin B ointment are limited[2][5].

Side Effects and Precautions

It is crucial for patients to be aware of the potential side effects and precautions associated with Bacitracin/Polymyxin B ointment, such as hypersensitivity reactions and the risk of overgrowth of nonsusceptible organisms[1].

Conclusion

The market for Bacitracin/Polymyxin B ointment is poised for growth, driven by increasing demand for effective antimicrobial agents. While prices are expected to remain relatively stable, factors such as competition, regulatory changes, and manufacturing costs can influence future pricing trends.

Key Takeaways

  • Market Growth: The global peptide antibiotics market, including Bacitracin/Polymyxin B, is expected to grow at a CAGR of 4.6% from 2022 to 2030.
  • Price Stability: Current prices for Bacitracin/Polymyxin B ointment are around $12.33 for 28.4 grams, with potential for slight increases.
  • Distribution Channels: Retail pharmacies are expected to see the fastest growth rate in distribution.
  • Regulatory Compliance: Manufacturers must adhere to strict regulatory guidelines.
  • Patient Resources: Patients can benefit from discount cards and copay programs.

FAQs

What is Bacitracin/Polymyxin B ointment used for?

Bacitracin/Polymyxin B ointment is used for the treatment of superficial ocular infections involving the conjunctiva and/or cornea, as well as bacterial skin infections[1].

How much does Bacitracin/Polymyxin B ointment cost?

The cost for Bacitracin/Polymyxin B topical ointment is around $12.33 for a supply of 28.4 grams, depending on the pharmacy and quantity purchased[2].

Are there any discount programs available for Bacitracin/Polymyxin B ointment?

Yes, patients can use discount cards and copay programs to reduce the cost of the medication. For example, the Drugs.com Discount Card can save up to 80% or more off the cost[2][5].

What are the potential side effects of Bacitracin/Polymyxin B ointment?

Potential side effects include hypersensitivity reactions and the risk of overgrowth of nonsusceptible organisms, including fungi[1].

Who are the key producers of Bacitracin/Polymyxin B ointment?

Key producers include companies like Xellia Pharmaceuticals, which have a robust product portfolio in peptide antibiotics[4].

Sources

  1. AK-POLY-BAC: Package Insert / Prescribing Information - Drugs.com
  2. Bacitracin/polymyxin b topical Prices, Coupons, Copay Cards & Patient Assistance - Drugs.com
  3. Global Bacitracin Zinc Ointment Supply, Demand and Key Producers, 2024-2030 - Market Research Reports
  4. Global Peptide Antibiotics Market Size & Share Report, 2030 - Grand View Research
  5. Bacitracin / neomycin / polymyxin b ophthalmic Prices, Coupons, Copay Cards & Patient Assistance - Drugs.com

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.